{{Rsnum
|rsid=2824292
|Chromosome=21
|position=17414857
|Orientation=plus
|GMAF=0.4559
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 29.2 | 50.4 | 20.4
| HCB | 23.4 | 48.2 | 28.5
| JPT | 10.6 | 48.7 | 40.7
| YRI | 12.9 | 32.7 | 54.4
| ASW | 10.7 | 33.9 | 55.4
| CHB | 23.4 | 48.2 | 28.5
| CHD | 21.3 | 45.4 | 33.3
| GIH | 39.0 | 47.0 | 14.0
| LWK | 5.5 | 49.1 | 45.5
| MEX | 19.3 | 52.6 | 28.1
| MKK | 6.4 | 42.3 | 51.3
| TSI | 30.4 | 46.1 | 23.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=24291282
|Title=Coxsackie and adenovirus receptor (CAR) is a modifier of cardiac conduction and arrhythmia vulnerability in the setting of myocardial ischemia
}}

{{PMID Auto
|PMID=20622880
|Title=Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction.
|OA=1
}}

{{PMID Auto
|PMID=21574885
|Title=No evidence for an association between the rs2824292 variant at chromosome 21q21 and ventricular fibrillation during acute myocardial infarction in a German population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}